Tag: Chelmsford
LifeVest Wearable Defibrillator Reduces Total Mortality By 36 Percent At 90...
The Landmark VEST Trial Shows 90-Day Use of LifeVest WCD Reduces Total Mortality After Heart Attack
CHELMSFORD, Mass., March 10, 2018 /PRNewswire/ -- ZOLL® Medical Corporation, an Asahi...
